The Claim
Daily administration of bempedoic acid at a dosage of 180 mg for six months reduces low-density lipoprotein cholesterol levels by a mean of 29.2 mg/dL (21.1 percentage points) in statin-intolerant patients with elevated LDL cholesterol compared to placebo.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people who cannot tolerate statins and have high LDL cholesterol, taking 180 mg of bempedoic acid daily for six months lowers LDL cholesterol by an average of 29.2 mg/dL compared to taking a placebo.
See the scientific wording
Among statin-intolerant patients with elevated LDL cholesterol, daily bempedoic acid (180 mg) reduces LDL cholesterol levels by a mean of 29.2 mg/dL (21.1 percentage points) after six months of treatment compared to placebo, providing a potent, orally available lipid-lowering option for this population.
Bempedoic acid enters the liver and is converted into an active form that blocks a key enzyme needed to make cholesterol. This causes liver cells to produce more receptors that pull LDL cholesterol out of the blood, lowering the amount of bad cholesterol circulating in the body.
What the research says
1 studyStudy: Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
For people who can't take statins, this big study found that taking bempedoic acid every day for six months lowered their bad cholesterol by about 29 mg/dL — just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.